[{"NetIncomeLossConverted_1_Q3_USD":-75887000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":230040000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":233379000.0,"RevenuesConverted_3_Q3_USD":2142853000.0,"RevenuesConverted_1_Q3_USD":634860000.0,"CommonStockSharesConverted_0_Q3_shares":230288796.0,"Assets_0_Q3_USD":9165243000.0,"EarningsPerShareBasic_1_Q3_USD":-0.33,"StockholdersEquity_0_Q3_USD":-782482000.0,"EarningsPerShareDiluted_3_Q3_USD":0.28,"EarningsPerShareDiluted_1_Q3_USD":-0.33,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":289443000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":228985000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":230040000.0,"NetIncomeLossConverted_3_Q3_USD":64601000.0,"CommonStockSharesOutstanding_0_Q3_shares":226802609.0,"EarningsPerShareBasic_3_Q3_USD":0.28,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201106"}]